Order Article Reprints

Sennato S, Paldino G, Bombelli C, Mezzani I, Petrini S, Belcastro E, Delfino DV, Fiorentino F, Marianecci C, Ciogli A, et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics. 2025; 17(12):1601. https://doi.org/10.3390/pharmaceutics17121601

Sennato, Simona, Giorgia Paldino, Cecilia Bombelli, Irene Mezzani, Stefania Petrini, Eugenia Belcastro, Domenico Vittorio Delfino, Francesco Fiorentino, Carlotta Marianecci, Alessia Ciogli, and et al. 2025. "Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710" Pharmaceutics 17, no. 12: 1601. https://doi.org/10.3390/pharmaceutics17121601

Sennato, S., Paldino, G., Bombelli, C., Mezzani, I., Petrini, S., Belcastro, E., Delfino, D. V., Fiorentino, F., Marianecci, C., Ciogli, A., Rotili, D., Ceccacci, F., & Fierabracci, A. (2025). Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics, 17(12), 1601. https://doi.org/10.3390/pharmaceutics17121601